Orciprenaline (Auramide)
Orciprenaline
Pharmacare limited û woodmead
Every registration of this product has been cancelled.
Registration
- Applicant
- Pharmacare limited û woodmead
- Registrations
- 2
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Auramide tablets EACH TABLET CONTAINS ORCIPRENALINE SULPHATE 20 mg | Tablets | L0330L/10.2/330 | Cancelled | Not determined | None |
| Auramide syrup EACH 5 ml SYRUP CONTAINS ORCIPRENALINE SULPHATE 10 mg | Syrup | N0200N/10.2/200 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Metaproterenol
- when intended for the prevention or delay of labour, and preparations thereof for injection. (S2, S3)
Consolidated Schedules 06 July 2026, lines 7079 to 7080
S3: Metaproterenol
- when contained in respirator solutions.
Consolidated Schedules 06 July 2026, line 3936
S2: Metaproterenol
- when contained in respirator solutions; (S3) and
- when intended for injection. (S4)
- when intended for the prevention or delay of labour, (S4)
Consolidated Schedules 06 July 2026, lines 2327 to 2333
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
5-[1-Hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol
Drag to rotate. Structure from PubChem CID 4086.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.